The Amyloidosis Program utilizes a multidisciplinary approach to evaluate and manage systematic amyloidosis with individualized treatment plans.

Located within Penn Medicine's Abramson Cancer Center, the Basser Center for BRCA is the first and only comprehensive center in the world solely devoted to funding research across the globe, educating providers and patients, and advancing care for individuals with BRCA gene mutations.

At Penn Medicine's Abramson Cancer Center, our clinicians and researchers are leading the way in the prevention, diagnosis and treatment of breast cancer.

The Bone Marrow and Stem Cell Transplant Program at the Abramson Cancer Center develops new treatments for hematologic malignancies.

The Brain Tumors Cancer Program offers the latest diagnostic and treatment advances for all types of brain tumors.

The Cancer Rehabilitation Program addresses the needs of cancer patients suffering from symptoms as a result of cancer or cancer treatment.

Penn’s Cancer Risk Evaluation Program helps assess your risk for different types of cancer by examining family history, age and reproductive history.

The Cancer Appetite and Rehabilitation Clinic helps to reduce the effects of cancer and cancer treatment through palliative and rehabilitative services.

Penn Medicine’s Center for Head and Neck Cancer provides leading edge diagnosis and treatment for all types of head and neck cancers.

The Center for Personalized Diagnostics seeks to identify genetic mutations within a patient's own cancer cells to design individualized treatment plans.